The Form 4 filing for SOPHiA GENETICS SA (SOPH) was submitted on October 14, 2026. Form 4 reports an insider's trades and changes in share ownership. It lists October 12, 2026, as the sale date, two days before the filing. Camblong Jurgi serves as the company's executive chairman.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-12 |
| Date of Latest Transaction | 2026-10-12 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 8,500 |
| Price | $7.26 |
| Total Transaction Value | $61,670.90 |
| Insider | |
| Ticker Symbol | SOPH |
| Company | SOPHiA GENETICS SA |
| Insider Name | Camblong Jurgi |
| Insider Title | Executive Chairman |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 3,387,150 |
| Position Size Change | 0.25% |
| Filing | |
| Filing Date | 2026-10-14 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of company shares, reported with SEC transaction code S. The transaction information lists one sale involving 8,500 shares.
What was the average price of the transaction?
The average price was $7.2554 per share. That rounds to $7.26 per share when shown in dollars and cents.
How did this transaction affect the insider's holdings?
The sale reduced Camblong Jurgi's reported holdings by 8,500 shares, leaving 3,387,150 shares. The shares sold made up 0.25% of the shares owned before the sale.
What's the total transaction value?
The total value was $61,670.90. That amount covers the single reported sale of 8,500 shares on October 12, 2026.
Are there any special circumstances around this transaction?
The filing information includes a Rule 10b5-1 plan reference. These plans set trading instructions in advance. The reference may apply to the filing as a whole. No footnote text is available to confirm whether it covers this specific sale. The plan's adoption date and trading schedule are unknown.
Source: SEC Form 4 for the October 12 transaction.
For research purposes only; not investment advice.